This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
According to vice president Ted Hill, it can modernize how public health agencies serve today’s needs. Casetivity can ingest, standardize, and share healthdata. The variety of organizations that provide data (clinical settings, labs, community-based organizations, etc.)
Verghese, and since you’re reading the Health Populi blog, you must get to know Dr. V now. Your first dip into his wisdom should be “A Doctor’s Touch,” his TED talk from 2011 with over 1.5 million views. You will thank me for pointing you to this pearl. You will want to know more.
So let’s take inventory: software for medical research, new sensor technology that provides activity data and remote diagnostics, health records, medical clinics and a powerful soft asset – consumer trust. Google started a health-records initiative in 2008, but shut it down by 2011, citing poor adoption.
Simultaneously, these biomarkers must be of sufficient direct value to patients to justify their participation in the data-collection effort. Greater investment in the science of digital biomarkers is needed to evaluate the value of mobile healthdata for clinical use. None of this is easy. billion in investments in 2018.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content